Literature DB >> 9682914

Endogenous marinobufagenin-like factor in acute plasma volume expansion.

O V Fedorova1, P A Doris, A Y Bagrov.   

Abstract

The aim of the study was to further investigate the nature of endogenous digitalis-like factors stimulated by acute plasma volume expansion (VE). 10 male Fisher 344XNB rats were given intravenous (iv) saline infusion (4% of the body mass) for 30 min, which caused a fall in % hematocrit (35.9+/-0.69 vs. 41.8+/-1.05; vs. 10 controls, P<0.01). EDLF was measured in C-18 reverse-phase extracted (32%+80% acetonitrile) tissues. VE was associated with an increase in plasma marinobufagenin-like factor (MLF)(0.49+/-0.05 vs. 0.2+/-0.06 nmol/L, P<0.01) and pituitary ouabain-like compound (OLC) (30.9+/-3.12 vs. 3.2+/-2.3 pmol/g, P<0.01). Plasma OLC decreased (0.087+/-0.018 vs. 0.21+/-0.04 nmol/L, P<0.02), and pituitary MLF did not change (0.05+/-0.01 vs. 0.07+/-0.02 pmol/g) after VE. Chloroform extracted urine from 5 volume-expanded male mongrel dogs was fractionated on reverse-phase HPLC columns in a linear gradient of 0-80% acetonitrile. The material cross-reacting with marinobufagenin antibody eluted from HPLC column as a single peak, demonstrated absorbance at 300 nm, and was distinct from ouabain-like material. Digoxin antibodies interacted with both marinobufagenin-like and ouabain-like immunoreactive material. These results provide further evidence for the presence of a bufodienolide EDLF in the mammals, and demonstrate that EDLF response to VE includes stimulation of brain OLC and plasma bufodienolide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682914     DOI: 10.3109/10641969809053236

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  30 in total

1.  Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.

Authors:  Hema Raina; Qingli Zhang; Albert Y Rhee; Thomas L Pallone; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

2.  Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure.

Authors:  David J Kennedy; Kevin Shrestha; Brendan Sheehey; Xinmin S Li; Anuradha Guggilam; Yuping Wu; Michael Finucan; Alaa Gabi; Charles M Medert; Kristen Westfall; Allen Borowski; Olga Fedorova; Alexei Y Bagrov; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2015-08-14       Impact factor: 8.790

Review 3.  The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades.

Authors:  Zhichuan Li; Zijian Xie
Journal:  Pflugers Arch       Date:  2008-02-19       Impact factor: 3.657

4.  Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.

Authors:  Arshani N Wansapura; Valerie Lasko; Zijian Xie; Olga V Fedorova; Alexei Y Bagrov; Jerry B Lingrel; John N Lorenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-17       Impact factor: 4.733

Review 5.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 6.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

7.  Ouabain-stimulated trafficking regulation of the Na/K-ATPase and NHE3 in renal proximal tubule cells.

Authors:  Yanling Yan; Steven Haller; Anna Shapiro; Nathan Malhotra; Jiang Tian; Zijian Xie; Deepak Malhotra; Joseph I Shapiro; Jiang Liu
Journal:  Mol Cell Biochem       Date:  2012-05-23       Impact factor: 3.396

Review 8.  Endogenous cardiotonic steroids and salt-sensitive hypertension.

Authors:  Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Biochim Biophys Acta       Date:  2010-03-27

Review 9.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

Review 10.  The Pressure of Aging.

Authors:  Majd AlGhatrif; Mingyi Wang; Olga V Fedorova; Alexei Y Bagrov; Edward G Lakatta
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.